🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested
The primary objective is to demonstrate the non-inferiority at six months o...
Status
Completed
Location
Investigational Site Number 204
Start Date
2009-07
Trial ID
NCT00965549
Treatments Being Tested
Primary Objective: To compare the insulin glargine/lixisenatide fixed rati...
Status
Completed
Location
Investigational Site Number 840027
Start Date
2014-02
Trial ID
NCT02058147
Primary Objective: To assess patient preference for Lantus SoloSTAR pen ve...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-10
Trial ID
NCT01226043
Treatments Being Tested
The objectives is to compare the changes in body composition (primary objec...
Status
Completed
Location
Institut de Recherches Cliniques de Montréal
Start Date
2009-03
Trial ID
NCT00862875
Treatments Being Tested
The primary objective was to demonstrate the superiority of insulin glargin...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-11
Trial ID
NCT00751114
Treatments Being Tested
The primary study objective was to compare the rate of "all hypoglycemia" (...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 840006
Start Date
2009-10
Trial ID
NCT00993473
Treatments Being Tested
Primary objective: To demonstrate the superiority of insulin glargine over...
Status
Completed
Location
Investigational Site Number 840023
Start Date
2010-07
Trial ID
NCT01117350
Treatments Being Tested
Primary Objective: \- To compare lixisenatide versus insulin glulisine in ...
Status
Completed
Location
Investigational Site Number 840043
Start Date
2013-01
Trial ID
NCT01768559
Primary Objective: * The purpose of this study was to compare insulin glar...
Status
Completed
Location
Investigational Site Number 840408
Start Date
2011-11
Trial ID
NCT01476475